Current Hypertension Reports

, Volume 4, Issue 2, pp 112–118 | Cite as

Obesity-related hypertension: Role of the sympathetic nervous system, insulin, and leptin

  • Kazuko Masuo


Heightened sympathetic nervous system activity, hyperinsulinemia, insulin resistance, and hyperleptinemia contribute to obesity-related hypertension. However, the precise mechanism and sequence of events in this pathophysiologic event have not been clarified. This review concentrates on studies helping to clarify the mechanisms of blood pressure elevation associated with weight change, concentrating on the temporal changes in neuroendocrine factors that are known to control energy metabolism and blood pressure. A better understanding of the pathophysiologic mechanisms of obesity-related hypertension may help in prevention, treatment, and slowing of the cardiovascular complications of obesity.


Blood Pressure Reduction Blood Pressure Elevation Blood Pressure Level Plasma Norepinephrine Sympathetic Nervous System Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Stamler R, Stamler J, Riedlinger WF, et al.: Weight and blood pressure: findings in hypertension screening of one million Americas. JAMA 1978, 240:1607–1610.PubMedCrossRefGoogle Scholar
  2. 2.
    Cassono PA, Segal MR, Vokonas PS, Weiss ST: Body fat distribution, blood pressure, and hypertension: a prospective cohort study of men in the Normative Aging Study. Ann Epidemiol 1990, 1:33–48.CrossRefGoogle Scholar
  3. 3.
    Tuck ML: Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992, 19(Suppl 1):167–177.Google Scholar
  4. 4.
    Narkiewicz K, Van de Bome PJ, Cooley RL, et al.: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998, 98:772–776.PubMedGoogle Scholar
  5. 5.
    Young JB, Macdonald IA: Sympathoadrenal activity in human obesity: heterogenity of findings since 1980. Int J Obes Relat Metab Disord 1992, 16:959–967.PubMedGoogle Scholar
  6. 6.
    Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 1999, 17:719–734.PubMedCrossRefGoogle Scholar
  7. 7.
    Rumantir MS, Vaz M, Jennings GL, et al.: Neural mechanisms in human obesity related hypertension. J Hypertens 1999, 17:1–9. This article compares the regional norepinephrine spillover rates from the heart, kidneys, and whole body.CrossRefGoogle Scholar
  8. 8.
    Grassi G, Seravalle G, Cattaneo BM, et al.: Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25[part 1]:560–563.PubMedGoogle Scholar
  9. 9.
    Anderson EA, Wallin BG, Mark AL: Dissociation of sympathetic nerve activity in arm and leg muscle during mental stress. Hypertension 1987, 9[suppl]:III114-III119.PubMedGoogle Scholar
  10. 10.
    Landsberg L: Diet, obesity and hypertension. A hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 236:1081–1090.Google Scholar
  11. 11.
    Landsberg L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertension 2001, 19:523–528. Excellent review of the association between sympathetic nervous system activity, insulin, and obesity-related hypertension.CrossRefGoogle Scholar
  12. 12.
    Julius S, Valentini M, Palatini P: Overweight and hypertension. A 2-way street? Hypertension 2000, 36:807–813. Another excellent review of the association between sympathetic nervous system activity, insulin, and obesity-related hypertension.Google Scholar
  13. 13.
    Julius S, Gudbrandsson T: Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovascular Pharmacol 1992, 20(suppl 8):S40-S48.Google Scholar
  14. 14.
    Julius S, Jamerson K: Sytmpathetics, insulin resistance and coronary risk in hypertension: the "chicken-and-egg" question. J Hypertens 1994, 12:495–502.PubMedCrossRefGoogle Scholar
  15. 15.
    Ward KD, Sparrow D, Landsberg L, et al.: Influence of insulin, sympathetic nebvous system activity, and obesity on blood pressure: the Normative Aging Study. J Hypertens 1996, 14:301–308.PubMedCrossRefGoogle Scholar
  16. 16.
    Troisi RJ, Weiss ST, Parker DR, et al.: Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991, 17:669–677.PubMedGoogle Scholar
  17. 17.
    Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens 1995, 13:1457–1462.PubMedGoogle Scholar
  18. 18.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Do reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients? Am J Hypertens 1996, 9:566–569.PubMedCrossRefGoogle Scholar
  19. 19.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 2000, 23:303–310.PubMedGoogle Scholar
  20. 20.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Prevalence of hyperinsulinemia in young, nonobese, Japanese men. J Hypertens 1997, 15:157–165.PubMedCrossRefGoogle Scholar
  21. 21.
    Agata J, Masuda A, Takada M, et al.: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997, 10:1171–1174.PubMedCrossRefGoogle Scholar
  22. 22.
    Narkiewicz K, Kato M, Phillips BG, et al.: Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001, 19:1089–1094.PubMedCrossRefGoogle Scholar
  23. 23.
    Schorr U, Blaschke K, Turan S, et al.: Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998, 16:1475–1480.PubMedCrossRefGoogle Scholar
  24. 24.
    Narkiewicz K, Somers VK, Mos L, et al.: An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens 1999, 17:245–249.PubMedGoogle Scholar
  25. 25.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Weight gain-induced blood pressure elevation. Hypertension 2000, 35:1135–1140. This article shows the precise mechanism of weight gain-induced blood pressure elevation in humans in a longitudinal study.PubMedGoogle Scholar
  26. 26.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens 2001, 14:530–538.PubMedCrossRefGoogle Scholar
  27. 27.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Differences in mechanisms between weight loss-sensitive and -resistant blood pressure reduction in obese subjects. Hypertens Res 2001, 24:371–376.PubMedCrossRefGoogle Scholar
  28. 28.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Familial obesity, sympathetic activation and blood pressure level. Blood Press 2001, 10:199–204.PubMedCrossRefGoogle Scholar
  29. 29.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 1998, 32:96–100.PubMedGoogle Scholar
  30. 30.
    Masuo K, Ogihara T, Kumahara Y, et al.: Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension. Hypertension 1983, 5:767–771.PubMedGoogle Scholar
  31. 31.
    Masuo K, Mikami H, Ogihara T, Tuck ML: Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997, 10:77–83.PubMedCrossRefGoogle Scholar
  32. 32.
    Anderson EA, Hoffman RP, Balon TW, et al.: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246–2252.PubMedCrossRefGoogle Scholar
  33. 33.
    Anderson EA, Balon TW, Hoffman RP, et al.: Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992, 19:621–627.PubMedGoogle Scholar
  34. 34.
    Rowe JW, Young JB, Minaker KL, et al.: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981, 30:218–225.Google Scholar
  35. 35.
    Cleland SJ, Ueda PS, Elliott HL, Connell JMC: Insulinmediated vasodilation and glucose uptake are functionally linked in humans. Hypertension 1999, 33[part II]:554–558.PubMedGoogle Scholar
  36. 36.
    Ferrannini E, Buzzigoli G, Bonadonna R, et al.: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350–357.PubMedCrossRefGoogle Scholar
  37. 37.
    Kawamura M, Adachi T, Nakajima J, et al.: Factors that affect calorie-sensitive and calorie-insensitive reduction in blood pressure during short-term calorie restriction in overweight hypertensive women. Hypertension 1996, 27:408–413.PubMedGoogle Scholar
  38. 38.
    Masuo K, Mikami H, Ogihara T, Tuck ML: The different mechanisms in weight loss-induced blood pressure reduction between a low caloric diet and exercise in obese subjects [abstract]. Hypertension 2001, In press.Google Scholar
  39. 39.
    Hirose H, Saito 1, Tsujioka M, et al.: Effects of body weight control on changes in blood pressure: three-year follow-up study in young Japanese individuals. Hypertens Res 2000, 23:421–426.PubMedGoogle Scholar
  40. 40.
    Tuck ML, Sowers JR, Dornfeld L, et al.: Reduction in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) 1983, 102:252–257.Google Scholar
  41. 41.
    Sowers JR, Whitfield LA, Catania RA, et al.: Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982, 54:1181–1186.PubMedCrossRefGoogle Scholar
  42. 42.
    Ikeda T, Gomi T, Hirawa N, et al.: Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 1996, 27:1180–1186.PubMedGoogle Scholar
  43. 43.
    Masuo K, Ogihara T: Mechanisms in obesity-related hypertension in humans [abstract 20]. Paper presented at Jackson Cardiovascular Renal Meeting. Jackson, MS. November 8-11, 2000.Google Scholar
  44. 44.
    The Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the sixth report. Arch Intern Med 1997, 157:2413–2446.Google Scholar
  45. 45.
    1999 World Health Organization-International Society of Hypertension: Guidelines for the management of hypertension: guideline subcommittee. J Hypertens 1999, 17:151–183.Google Scholar
  46. 46.
    Grassi G, Seravalle G, Calhoun D, Mancia G: Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension 1994, 23:294–301.PubMedGoogle Scholar
  47. 47.
    Jennings G, Nelson L, Nestel P, et al.: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986, 73:30–40.PubMedGoogle Scholar
  48. 48.
    Ferrier KE, Waddell TK, Gatzka CD, et al.: Aerobic exercise training does not modify large-artery compliance in isolated hypertension. Hypertension 2001, 38:222–226.PubMedGoogle Scholar
  49. 49.
    Narkiewicz K, Szczech R, Winnicki M, et al.: Heritability of plasma leptin levels: a twin study. J Hypertens 1999, 17:27–31.PubMedGoogle Scholar
  50. 50.
    Ostlund RE Jr, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1995, 81:3909–3913.CrossRefGoogle Scholar
  51. 51.
    Mark AL, Anderson EA: Genetic factors determine the blood pressure response to insulin resistance and hyperinsulinemia: A call to refocus the insulin hypothesis of hypertension. Proc Soc Exp Biol Med 1995, 208:330–336.PubMedGoogle Scholar
  52. 52.
    Simsolo RB, Romo MM, Rabinovich L, et al.: Family history of essential hypertension versus obesity as risk factors for hypertension in adolescents. Am J Hypertens 1999, 12:260–263.PubMedCrossRefGoogle Scholar
  53. 53.
    Ishibashi F: Higher serum insulin level due to greater total body fat mass in offspring of patients with essential hypertension. Diabetes Res Clin Pract 1993, 20:63–68.PubMedCrossRefGoogle Scholar
  54. 54.
    Neutel JM, Smith DH, Graettinger WF, et al.: Metabolic characteristics of hypertension: importance of a positive family history. Am Heart J 1993, 126:924–929.PubMedCrossRefGoogle Scholar
  55. 55.
    Gutersohn A, Mueller R, Siffert W: High blood pressure gene also linked to obesity. Paper presented at American Heart Association Meeting. New Orleans. November 13, 2000.Google Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Kazuko Masuo
    • 1
  1. 1.Department of Geriatric MedicineOsaka University Graduate School of MedicineOsakaJapan

Personalised recommendations